Table 3 CMV characteristics
Number of eyes, n | 53 |
Location, n (%) | |
Zone 1 | 15 (28.3) |
Zone 2 | 23 (43.4) |
Zone 3 | 11 (20.8) |
CMVR involvement retinal area, n (%) | |
<25 % | 40 (75.5) |
25–50 % | 9 (17.0) |
>50 % | 4 (7.5) |
Duration, days; median (IQR) | |
From HIV diagnosis to CMVR diagnosis | 283.0 (142.0–539.5) |
From CMVR diagnosis to anti-CMVR treatment | 0.0 (0.0–0.0) |